ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,186Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 298

$427K Total Retail Price of All Prescriptions

Rank: 53 out of 298

347 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 347 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 347 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 11,756 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 660 648 1 1
HYDROCHLOROTHIAZIDE 630 616 2 13
AMLODIPINE BESYLATE 591 570 3 6
LISINOPRIL 561 539 4 4
WARFARIN SODIUM 520 492 5 7
METOPROLOL SUCCINATE 357 331 6 12
FUROSEMIDE 355 353 7 5
METOPROLOL TARTRATE 334 322 8 9
SIMVASTATIN 323 322 9 2
ATORVASTATIN CALCIUM 296 281 10 14
SERTRALINE HCL 252 236 11 19
OMEPRAZOLE 247 247 12 3
ATENOLOL 233 213 13 16
POTASSIUM CHLORIDE 233 231 13 11
METFORMIN HCL 212 199 15 10
POLYETHYLENE GLYCOL 3350 183 183 16 29
CARVEDILOL 180 178 17 23
HYDROCODONE-ACETAMINOPHEN 168 165 S3 18 8
DONEPEZIL HCL 164 164 19 22
LOSARTAN POTASSIUM 159 146 20 18
MIRTAZAPINE 156 156 21 37
GLIMEPIRIDE 150 144 22 60
DIOVAN 145 145 23 47
METFORMIN HCL ER 130 123 24 57
ENALAPRIL MALEATE 111 111 25 58
CITALOPRAM HBR 109 109 26 17
ALENDRONATE SODIUM 106 91 27 21
ALLOPURINOL 104 94 28 28
LANTUS 101 83 29 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 97 30 30
PRAVASTATIN SODIUM 95 95 31 31
TAMSULOSIN HCL 89 88 32 24
LOSARTAN-HYDROCHLOROTHIAZIDE 88 80 33 44
CARBIDOPA-LEVODOPA 80 71 34 49
ZOLPIDEM TARTRATE 80 80 34 25
DIGOXIN 79 77 36 27
PRAMIPEXOLE DIHYDROCHLORIDE 78 78 37 114
TRIAMTERENE-HCTZ 77 66 38 43
DILT-XR 73 73 39 208
TRAMADOL HCL 73 73 39 15
TRAZODONE HCL 72 72 41 39
CRESTOR 72 72 41 26
LOVASTATIN 71 71 43 64
BUSPIRONE HCL 70 70 44 152
HUMULIN 70-30 65 65 45 160
PREDNISONE 63 63 46 33
FLUTICASONE PROPIONATE 63 62 46 38
HUMALOG 62 55 48 217
GLIPIZIDE 61 61 49 69
LABETALOL HCL 60 60 50 87
NAMENDA 59 59 51 35
FAMOTIDINE 59 59 51 80
INSULIN SYRINGE 59 47 51 99
CLOPIDOGREL 58 58 54 36
NOVOLIN 70-30 57 57 55 184
GABAPENTIN 51 51 56 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.